NEO
Price
$8.84
Change
+$0.06 (+0.68%)
Updated
Apr 7, 04:59 PM (EDT)
Capitalization
2.01B
29 days until earnings call
RGEN
Price
$116.10
Change
+$4.16 (+3.72%)
Updated
Apr 7, 04:59 PM (EDT)
Capitalization
10.26B
23 days until earnings call
Ad is loading...

NEO vs RGEN

Header iconNEO vs RGEN Comparison
Open Charts NEO vs RGENBanner chart's image
NeoGenomics
Price$8.84
Change+$0.06 (+0.68%)
Volume$36.43K
Capitalization2.01B
Repligen
Price$116.10
Change+$4.16 (+3.72%)
Volume$15.9K
Capitalization10.26B
NEO vs RGEN Comparison Chart
Loading...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NEO vs. RGEN commentary
Apr 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NEO is a Hold and RGEN is a Hold.

Ad is loading...
COMPARISON
Comparison
Apr 08, 2025
Stock price -- (NEO: $8.78 vs. RGEN: $111.94)
Brand notoriety: NEO and RGEN are both not notable
Both companies represent the Medical Specialties industry
Current volume relative to the 65-day Moving Average: NEO: 151% vs. RGEN: 252%
Market capitalization -- NEO: $2.01B vs. RGEN: $10.26B
NEO [@Medical Specialties] is valued at $2.01B. RGEN’s [@Medical Specialties] market capitalization is $10.26B. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Medical Specialties] industry is $8.33B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NEO’s FA Score shows that 0 FA rating(s) are green whileRGEN’s FA Score has 1 green FA rating(s).

  • NEO’s FA Score: 0 green, 5 red.
  • RGEN’s FA Score: 1 green, 4 red.
According to our system of comparison, RGEN is a better buy in the long-term than NEO.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NEO’s TA Score shows that 4 TA indicator(s) are bullish while RGEN’s TA Score has 4 bullish TA indicator(s).

  • NEO’s TA Score: 4 bullish, 3 bearish.
  • RGEN’s TA Score: 4 bullish, 6 bearish.
According to our system of comparison, NEO is a better buy in the short-term than RGEN.

Price Growth

NEO (@Medical Specialties) experienced а -8.73% price change this week, while RGEN (@Medical Specialties) price change was -16.09% for the same time period.

The average weekly price growth across all stocks in the @Medical Specialties industry was -5.15%. For the same industry, the average monthly price growth was -1.39%, and the average quarterly price growth was -0.16%.

Reported Earning Dates

NEO is expected to report earnings on May 06, 2025.

RGEN is expected to report earnings on Apr 30, 2025.

Industries' Descriptions

@Medical Specialties (-5.15% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RGEN($10.3B) has a higher market cap than NEO($2.01B). RGEN has higher P/E ratio than NEO: RGEN (247.52) vs NEO (49.50). RGEN YTD gains are higher at: -22.231 vs. NEO (-46.723). RGEN has higher annual earnings (EBITDA): 134M vs. NEO (-17.61M). RGEN has more cash in the bank: 751M vs. NEO (415M). NEO has less debt than RGEN: NEO (612M) vs RGEN (712M). RGEN has higher revenues than NEO: RGEN (639M) vs NEO (592M).
NEORGENNEO / RGEN
Capitalization2.01B10.3B19%
EBITDA-17.61M134M-13%
Gain YTD-46.723-22.231210%
P/E Ratio49.50247.5220%
Revenue592M639M93%
Total Cash415M751M55%
Total Debt612M712M86%
FUNDAMENTALS RATINGS
NEO vs RGEN: Fundamental Ratings
NEO
RGEN
OUTLOOK RATING
1..100
6459
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
95
Overvalued
PROFIT vs RISK RATING
1..100
10080
SMR RATING
1..100
9290
PRICE GROWTH RATING
1..100
8782
P/E GROWTH RATING
1..100
1002
SEASONALITY SCORE
1..100
n/an/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

NEO's Valuation (72) in the Medical Or Nursing Services industry is in the same range as RGEN (95) in the Biotechnology industry. This means that NEO’s stock grew similarly to RGEN’s over the last 12 months.

RGEN's Profit vs Risk Rating (80) in the Biotechnology industry is in the same range as NEO (100) in the Medical Or Nursing Services industry. This means that RGEN’s stock grew similarly to NEO’s over the last 12 months.

RGEN's SMR Rating (90) in the Biotechnology industry is in the same range as NEO (92) in the Medical Or Nursing Services industry. This means that RGEN’s stock grew similarly to NEO’s over the last 12 months.

RGEN's Price Growth Rating (82) in the Biotechnology industry is in the same range as NEO (87) in the Medical Or Nursing Services industry. This means that RGEN’s stock grew similarly to NEO’s over the last 12 months.

RGEN's P/E Growth Rating (2) in the Biotechnology industry is significantly better than the same rating for NEO (100) in the Medical Or Nursing Services industry. This means that RGEN’s stock grew significantly faster than NEO’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
NEORGEN
RSI
ODDS (%)
Bullish Trend 7 days ago
90%
Bullish Trend 7 days ago
83%
Stochastic
ODDS (%)
Bullish Trend 7 days ago
77%
Bullish Trend 7 days ago
80%
Momentum
ODDS (%)
Bearish Trend 7 days ago
79%
Bearish Trend 7 days ago
76%
MACD
ODDS (%)
Bullish Trend 7 days ago
77%
Bearish Trend 7 days ago
80%
TrendWeek
ODDS (%)
Bearish Trend 7 days ago
82%
Bearish Trend 7 days ago
76%
TrendMonth
ODDS (%)
Bearish Trend 7 days ago
79%
Bearish Trend 7 days ago
78%
Advances
ODDS (%)
Bullish Trend 11 days ago
78%
Bullish Trend 15 days ago
77%
Declines
ODDS (%)
Bearish Trend 7 days ago
81%
Bearish Trend 8 days ago
79%
BollingerBands
ODDS (%)
N/A
Bullish Trend 7 days ago
79%
Aroon
ODDS (%)
Bearish Trend 7 days ago
85%
Bearish Trend 7 days ago
76%
View a ticker or compare two or three
Ad is loading...
NEO
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RGEN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GME23.492.39
+11.33%
GameStop Corp
SPY505.28-31.42
-5.85%
SPDR® S&P 500® ETF Trust
BTC.X78214.484000-5290.312500
-6.34%
Bitcoin cryptocurrency
AAPL188.38-14.81
-7.29%
Apple
TSLA239.43-27.85
-10.42%
Tesla

NEO and

Correlation & Price change

A.I.dvisor indicates that over the last year, NEO has been loosely correlated with FLGT. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if NEO jumps, then FLGT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NEO
1D Price
Change %
NEO100%
+0.69%
FLGT - NEO
44%
Loosely correlated
-0.82%
RGEN - NEO
41%
Loosely correlated
-8.02%
CSTL - NEO
40%
Loosely correlated
-3.23%
VCYT - NEO
39%
Loosely correlated
+1.69%
BLFS - NEO
39%
Loosely correlated
-6.95%
More

RGEN and

Correlation & Price change

A.I.dvisor indicates that over the last year, RGEN has been loosely correlated with BIO. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if RGEN jumps, then BIO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To RGEN
1D Price
Change %
RGEN100%
-8.02%
BIO - RGEN
54%
Loosely correlated
-3.90%
BLFS - RGEN
49%
Loosely correlated
-6.95%
DHR - RGEN
49%
Loosely correlated
-8.15%
A - RGEN
46%
Loosely correlated
-6.08%
WAT - RGEN
44%
Loosely correlated
-5.85%
More